VolitionRx Limited (VNRX)
Largest Insider Buys in Sector
VNRX Stock Price History Chart
VNRX Stock Performance
About VolitionRx Limited
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, …
Insider Activity of VolitionRx Limited
Over the last 12 months, insiders at VolitionRx Limited have bought $181,700 and sold $33,000 worth of VolitionRx Limited stock.
On average, over the past 5 years, insiders at VolitionRx Limited have bought $441,409 and sold $246,254 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Innes Guy Archibald (director) — $137,700. Butera Salvatore Thomas (CEO - Volition Veterinary) — $24,100. Futcher Edward (director) — $7,200.
The last purchase of 150,000 shares for transaction amount of $100,500 was made by Innes Guy Archibald (director) on 2024‑08‑20.
List of Insider Buy and Sell Transactions, VolitionRx Limited
| 2024-08-20 | director | 150,000 0.1651% | $0.67 | $100,500 | +4.70% | |||
| 2024-01-02 | Sale | 10 percent owner | 20,000 0.0222% | $0.90 | $18,000 | -30.05% | ||
| 2023-12-18 | CEO - Volition Veterinary | 10,000 0.0135% | $0.83 | $8,300 | -4.71% | |||
| 2023-12-15 | Sale | 10 percent owner | 20,000 0.0244% | $0.75 | $15,000 | -2.75% | ||
| 2023-12-15 | CEO - Volition Veterinary | 10,000 0.0125% | $0.77 | $7,700 | -2.75% | |||
| 2023-12-13 | Secretary | 10,000 0.0133% | $0.60 | $6,000 | +29.11% | |||
| 2023-12-08 | President and CEO | 10,000 0.0131% | $0.67 | $6,700 | +12.73% | |||
| 2023-11-27 | director | 20,000 0.0247% | $0.77 | $15,400 | -5.06% | |||
| 2023-11-27 | director | 9,000 0.0115% | $0.80 | $7,200 | -5.06% | |||
| 2023-11-24 | director | 10,000 0.013% | $0.76 | $7,600 | -1.51% | |||
| 2023-11-22 | director | 20,000 0.0252% | $0.71 | $14,200 | +1.51% | |||
| 2023-11-16 | CEO - Volition Veterinary | 10,000 0.0134% | $0.81 | $8,100 | -4.84% | |||
| 2023-09-05 | director | 5,000 0.0066% | $1.30 | $6,500 | -39.54% | |||
| 2023-08-31 | director | 9,716 0.0127% | $1.28 | $12,436 | -39.92% | |||
| 2023-08-31 | director | 3,706 0.0047% | $1.25 | $4,633 | -39.92% | |||
| 2023-08-30 | Chief Scientific Officer | 8,750 0.0113% | $1.27 | $11,113 | -39.36% | |||
| 2023-08-29 | Chief Scientific Officer | 11,250 0.0142% | $1.24 | $13,950 | -40.24% | |||
| 2023-08-25 | Chief Scientific Officer | 20,000 0.0258% | $1.24 | $24,800 | -37.46% | |||
| 2023-08-24 | Chief Operating Officer | 5,000 0.0064% | $1.23 | $6,150 | -35.87% | |||
| 2023-08-24 | director | 5,000 0.0063% | $1.22 | $6,100 | -35.87% |
Insider Historical Profitability
| Reynolds Cameron John | President and CEO | 1704518 1.8507% | $0.64 | 8 | 2 | +12.08% |
| Innes Guy Archibald | director | 406683 0.4416% | $0.64 | 11 | 0 | <0.0001% |
| Eight Corp Ltd | 10 percent owner | 298419 0.324% | $0.64 | 1 | 3 | <0.0001% |
| Butera Salvatore Thomas | CEO - Volition Veterinary | 99350 0.1079% | $0.64 | 13 | 0 | <0.0001% |
| Rootsaert Rodney Gerard | Secretary | 78652 0.0854% | $0.64 | 3 | 1 | +31.58% |
Institutional Investor Ownership
| LAGODA INVESTMENT MANAGEMENT, LP | $3.84M | 6.12 | 5.07M | +36.06% | +$1.02M | 2.36 | |
| The Vanguard Group | $481,579.00 | 0.77 | 636,167 | +1.04% | +$4,941.70 | <0.0001 | |
| Geode Capital Management | $467,464.00 | 0.74 | 617,366 | +10.76% | +$45,395.87 | <0.0001 | |
| BlackRock | $434,336.00 | 0.69 | 573,760 | -0.55% | -$2,395.15 | <0.0001 | |
| Bridgeway Capital Management | $131,854.00 | 0.21 | 174,180 | -1.09% | -$1,453.44 | <0.01 |